Hemoderivative Transfusion in Liver Transplantation: Comparison Between Recipients of Grafts From Brain Death Donors

Iago Justo1, Alberto Marcacuzco1, Oscar Caso1

  • 1Unit of HPB Surgery and Abdominal Organ Transplantation, Department of General Surgery, "Doce de Octubre" University Hospital, Instituto de Investigación (Imas12), Faculty of Medicine, Complutense University, Madrid, Spain.

Insights

Liver transplantation using grafts from donors after circulatory death (DCD) requires more blood transfusions than those from brain-dead donors. This highlights the need for careful management of DCD liver grafts to optimize patient outcomes.

Area of Science:

  • Transplantation immunology
  • Hepatobiliary surgery
  • Organ donation and procurement

Background:

  • Intraoperative bleeding during liver transplantation is linked to increased morbidity, mortality, and reduced patient/graft survival.
  • Optimizing graft utilization is crucial for improving liver transplant outcomes.
  • Understanding differences between donor types can inform surgical strategies.

Purpose of the Study:

  • To compare the outcomes of liver transplantation using grafts from donors after circulatory death (DCD) versus donors after brain death (DBD).
  • To investigate the association between graft type and the requirement for blood product transfusion.
  • To identify factors influencing massive blood transfusions in liver transplantation.

Main Methods:

  • A retrospective analysis of 783 orthotopic liver transplants performed between January 2006 and December 2016.
  • Comparison of liver grafts from DCD donors (n=69) versus DBD donors (n=265).
  • Statistical analysis of patient demographics, perioperative variables, transfusion requirements, and survival rates.

Main Results:

  • No significant differences in patient demographics or pre-transplant scores (MELD, Child-Pugh) between DCD and DBD groups.
  • Grafts from DCD donors required significantly more red blood cell (9 vs 6 units) and fresh frozen plasma (10 vs 9.5 units) transfusions (P < .004).
  • Uncontrolled DCD status and higher MELD scores were independently associated with massive blood transfusion (>6 RBC units).

Conclusions:

  • Liver grafts from DCD donors are associated with a higher need for hemoderivative transfusions compared to grafts from DBD donors.
  • The findings underscore the importance of managing transfusion needs in DCD liver transplant recipients.
  • Further research may explore strategies to mitigate transfusion requirements with DCD grafts.
Abstract

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
948
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
93
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
585
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.9K